178 IMMUNOSUPPRESSION AND HEPATOCELLULAR CARCINOMA RECURRENCE AFTER LIVER TRANSPLANTATION
| Autor: | Manuel Rodríguez-Perálvarez, D. Thorburn, Emmanuel Tsochatzis, Carmen García-Caparrós, M. de la Mata, Antonio Poyato-González, G. Pieri, A.K. Burroughs, M.C. Naveas, G. Ferrín-Sa'nchez, Javier Briceño, David Patch, José Luis Montero-Álvarez, James O'Beirne |
|---|---|
| Rok vydání: | 2013 |
| Předmět: |
medicine.medical_specialty
Hepatology business.industry medicine.medical_treatment Silibinin Hcv recurrence Immunosuppression Liver transplantation medicine.disease Gastroenterology chemistry.chemical_compound Clinical research chemistry Hepatocellular carcinoma Internal medicine medicine In patient business |
| Zdroj: | Journal of Hepatology. 58:S78-S79 |
| ISSN: | 0168-8278 |
| Popis: | 176 PROSPECTIVE, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PILOT STUDY EVALUATING EFFICACY AND SAFETY OF INTRAVENOUS SILIBININ IN PATIENTS WITH HCV RECURRENCE ON THE GRAFT AFTER LIVER TRANSPLANTATION M. Rendina, M. D’Amato, A. Castellaneta, N.M. Castellaneta, N. Brambilla, G. Giacovelli, L. Rovati, S.F. Rizzi, M. Zappimbulso, R. Bringiotti, A. Di Leo. Gastroenterology, University of Bari, Bari, Clinical Research, Rottapharm SpA, Milan, Italy E-mail: mariarendina@virgilio.it |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect